Study ID: IXL-202-18-189
Study Title
- Effects of Talampanel on Patients With Advanced Parkinson's Disease
Teva Identifier
- IXL-202-18-189
ClinicalTrials.gov Identifier
- NCT00036296
Study Status
- Completed
Trial Condition(s)
- Dyskinesias | Parkinson Disease | Movement Disorders
Interventions
- Drug: talampanel
Study Description
- Please refer to ClinicalTrials.gov for a description of the trial
Key Participation Requirements
Gender
- Female, Male
Age Range
- 40 Years to 85 Years
Trial Duration
- 12/01/2006 - 02/01/2007
Phase
- Phase 1/2
Study Type
Interventional
